Business Context and Reporting Period
Company: Lifecore Biomedical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 20, 2024
Context: This filing announces the submission of the Company's Annual Report on Form 10-K for the fiscal year ended May 28, 2023. It also references the availability of a supplementary summary of select financial data on the Company's website.
Key Financial Metrics
The provided 8-K filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the Form 10-K and the Supplemental Presentation (Exhibits 99.1 and 99.2), which are incorporated by reference but not detailed in this specific document text.
Material Changes
The filing notes that the referenced Form 10-K contains restated financial information. Specific details regarding the nature or magnitude of these restatements are not provided in the 8-K text itself.
Guidance, Outlook, and Risks
Management Commentary: The filing serves primarily as a notification of the 10-K filing and the availability of supplemental data. No forward-looking guidance or specific management commentary is included in the text of this 8-K.
Legal Disclaimer: The information contained in the press release and supplemental presentation is explicitly stated not to be deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other Company filings.
Investor Verification Checklist
- Review the full Form 10-K for the fiscal year ended May 28, 2023, to obtain actual financial figures.
- Examine the "restated financial information" mentioned in the filing to understand the impact on prior period results.
- Access the Supplemental Presentation (Exhibit 99.2) for select financial data summaries.
- Verify the press release (Exhibit 99.1) for any qualitative updates on operations not captured in the 8-K summary.